Kyverna Therapeutics (KYTX) Technical Analysis
As of 2026-10-26, KYTX last traded at 5.27 USD (-2.23% on the day) and is in a range on the daily timeframe — insufficient history for 200-DMA. Nearest levels: no clear near support below, 6.58 USD resistance above. 14-day RSI is 33.3 (bearish).
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
Is KYTX in an uptrend or downtrend?
Kyverna Therapeutics is in a range — insufficient history for 200-DMA.
| Last close | 5.27 USD (-2.23%) |
|---|---|
| 20-day average | 6.05 USD |
| 50-day average | 7.06 USD |
| 200-day average | n/a |
Key support and resistance levels for KYTX
Derived from swing pivots over the last 69 sessions:
| Level | Type | Strength | Touches |
|---|---|---|---|
| 6.58 USD | Resistance | Minor | 1 |
| 7.91 USD | Resistance | Minor | 1 |
| 7.98 USD | Resistance | Minor | 1 |
No clearly-defined swing levels in the current range.
KYTX 52-week range, momentum and volatility
| 52-week high | 10.19 USD (48.3% below) |
|---|---|
| 52-week low | 5.18 USD (1.7% above) |
| 14-day RSI | 33.3 (Bearish) |
| 14-day ATR | 0.336 USD (6.37% of price, High volatility) |
Related research pages
More on KYTX
Frequently asked questions
Is Kyverna Therapeutics (KYTX) in an uptrend or downtrend?
As of 2026-10-26, KYTX is in a range on the daily timeframe — insufficient history for 200-DMA. Last close 5.27 USD vs 50-day average 7.06 USD and 200-day average n/a.
What are the key support and resistance levels for KYTX?
No clear support below price in range. Nearest resistance is around 6.58 USD (minor). Levels are derived from swing pivots over the last ~200 sessions.
What is KYTX's 52-week high and low?
Over the last 52 weeks, KYTX traded between 5.18 USD and 10.19 USD. It is currently 48.3% below its 52-week high.
Is KYTX overbought or oversold?
The 14-day RSI is 33.3 — in a neutral 30–70 range. Momentum reads as bearish.
How volatile is KYTX?
Its 14-day Average True Range is 0.336 (6.37% of price) — high volatility relative to price.